Detalhe da pesquisa
1.
Aberrant activation of five embryonic stem cell-specific genes robustly predicts a high risk of relapse in breast cancers.
BMC Genomics
; 24(1): 463, 2023 Aug 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37592220
2.
Impact of creative art therapy on fatigue and quality of life in patients treated for localized breast cancer: A randomized study.
Psychooncology
; 31(8): 1412-1419, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35488808
3.
Impact of multidisciplinary tumour board in the management of ovarian carcinoma in the first-line setting. Exhaustive analysis from the Rhone-Alpes region.
Eur J Cancer Care (Engl)
; 29(6): e13313, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32894629
4.
Feasibility of Real-Time Intraprocedural Temperature Control during Bone Metastasis Thermal Microwave Ablation: A Bicentric Retrospective Study.
J Vasc Interv Radiol
; 28(3): 366-371, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28007329
5.
Fixed drug eruption caused by fulvestrant confirmed by skin tests: First case.
Contact Dermatitis
; 80(3): 184-186, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30461027
6.
Trastuzumab deruxtecan in previously treated HER2-positive metastatic or unresectable breast cancer: Real-life data from the temporary use authorization program in France.
Cancer Med
; 13(9): e7168, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38733172
7.
Characterizing consumer health terminology in the breast cancer field.
Stud Health Technol Inform
; 160(Pt 2): 991-4, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20841832
8.
Kinetics of HER2/neu ECD in 45 patients treated with trastuzumab (Herceptin) between January 2001 and June 2005 at the Grenoble University Hospital.
Anticancer Res
; 29(5): 1703-7, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19443390
9.
Erythropoietin pretreatment protects against acute chemotherapy toxicity in isolated rat hearts.
Exp Biol Med (Maywood)
; 233(1): 76-83, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18156309
10.
Evaluation of a manual ELISA kit for determination of HER2/neu in serum of breast cancer patients.
Anticancer Res
; 28(5B): 3067-73, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-19031958
11.
[Prevalence of pain in radiotherapy and improvement of its management]. / Prévalence de la douleur en radiothérapie et amélioration de sa prise en charge.
Bull Cancer
; 105(12): 1183-1192, 2018 Dec.
Artigo
em Francês
| MEDLINE | ID: mdl-30366592
12.
New advances in DPYD genotype and risk of severe toxicity under capecitabine.
PLoS One
; 12(5): e0175998, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28481884
13.
Prospect for anti-HER2 receptor therapy in breast cancer.
Anticancer Res
; 26(1B): 463-70, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-16739306
14.
Prospect for anti-her2 receptor therapy in breast cancer.
Anticancer Res
; 26(1B): 715-22, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-16739343
15.
A model for the measurement of patient activity in a hospital suite.
IEEE Trans Inf Technol Biomed
; 10(1): 92-9, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16445254
16.
Leukocyte 8-oxo-7,8-dihydro-2'-deoxyguanosine and comet assay in epirubicin-treated patients.
Free Radic Res
; 39(8): 837-43, 2005 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16036363
17.
Prognostic impact of paraneoplastic cushing's syndrome in small-cell lung cancer.
J Thorac Oncol
; 9(4): 497-505, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24736072
18.
Monitoring monoclonal antibody delivery in oncology: the example of bevacizumab.
PLoS One
; 8(8): e72021, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23951280
19.
Factors for hematopoietic toxicity of carboplatin: refining the targeting of carboplatin systemic exposure.
J Clin Oncol
; 28(30): 4568-74, 2010 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-20855828
20.
Treatment of metastatic breast cancer: a large observational study on adherence to French prescribing guidelines and financial cost of the anti-HER2 antibody trastuzumab.
Am J Clin Oncol
; 32(4): 369-74, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19381078